title: A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge.
abstract: C3H/HeN female mice were vaccinated with native Chlamydia muridarum major outer membrane protein (MOMP), using Montanide+CpG or Alum+CpG as adjuvants. Negative control groups were immunized with ovalbumin (OVA) and the same adjuvants. As positive control, mice were inoculated intranasally with live Chlamydia. Mice were challenged in the ovarian bursa with 10(5) C. muridarum inclusion forming units. Six weeks after the genital challenge the animals were caged with male mice and monitored for pregnancy. Mice vaccinated with MOMP+Montanide+CpG developed high levels of C. muridarum-specific antibodies, with a high IgG2a/IgG1 ratio and neutralizing titres. Animals immunized using Alum+CpG had low antibody levels. Cellular immune responses were significantly higher in mice vaccinated with MOMP and Montanide+CpG, but not with Alum+CpG, when compared with negative controls. Following the genital challenge, only 20% (4/20) of mice vaccinated with MOMP+CpG+Montanide had positive vaginal cultures whereas 100% (9/9) of mice immunized with MOMP+CpG+Alum had positive cultures. Of the positive control animals inoculated with live Chlamydia only 15% (3/20) had positive vaginal cultures. In contrast, 100% (20/20) of mice immunized with OVA+CpG+Montanide, or minimal essential medium, had positive cultures. Following mating, 80% (16/20) of mice vaccinated with MOMP+CpG+Montanide, and 85% (17/20) of animals inoculated intranasally with live C. muridarum carried embryos in both uterine horns. No protection against infertility was observed in mice immunized with MOMP and CpG+Alum or OVA. In conclusion, this is the first time that a subunit vaccine has been shown to elicit a protective immune response in the highly susceptible C3H/HeN strain of mice against an upper genital challenge.
authors.affiliation: Department of Pathology and Laboratory Medicine, Medical Sciences I, University of California, Irvine, Irvine, CA, USA.
authors.forename: Sukumar
authors.initials: S
authors.lastname: Pal
authors.affiliation: Department of Pathology and Laboratory Medicine, Medical Sciences I, University of California, Irvine, Irvine, CA, USA.
authors.forename: Olga V
authors.initials: OV
authors.lastname: Tatarenkova
authors.affiliation: Department of Pathology and Laboratory Medicine, Medical Sciences I, University of California, Irvine, Irvine, CA, USA.
authors.forename: Luis M
authors.initials: LM
authors.lastname: de la Maza
mesh_terms: D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood / Q000378:metabolism; D001425:Bacterial Outer Membrane Proteins / Q000276:immunology*; D001428:Bacterial Vaccines / Q000276:immunology* / Q000494:pharmacology*; D002690:Chlamydia Infections / Q000276:immunology* / Q000382:microbiology / Q000517:prevention & control*; D023502:Chlamydia muridarum / Q000276:immunology* / Q000472:pathogenicity*; D004195:Disease Models, Animal; D004198:Disease Susceptibility; D005260:Female; D005298:Fertility / Q000276:immunology; D005831:Genital Diseases, Female / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control; D007111:Immunity, Cellular; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D010053:Ovary / Q000276:immunology / Q000382:microbiology; D011247:Pregnancy; D022223:Vaccines, Subunit / Q000276:immunology / Q000494:pharmacology; D014621:Vagina / Q000276:immunology / Q000382:microbiology
chemical_list: D000907:Antibodies, Bacterial; D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D022223:Vaccines, Subunit
keywords: Chlamydia muridarum; adjuvants; immunization; major outer membrane protein; mice